Freeze Dried Plasma HT9425-25-JA-TJK1
Summary
AI-generated · Aug 24, 2025Critical requirement to supply Freeze Dried Plasma under an FDA-authorized Emergency Use Authorization with Octapharma USA Inc to provide OctaplasLG Powder (blood group types A and AB) for Department of Defense use to treat hemorrhage or coagulopathy during emergencies involving military combat when plasma is unavailable or impractical. This product is authorized under the FDA’s Emergency Use Authorization pursuant to the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb-3).
USAMMDA, WPAC PMO has a critical requirement for Freeze Dried Plasma (FDP) available under a Food and Drug Administration (FDA) authorized Emergency Use Authorization (EUA) with Octapharma USA Inc, 117 W Century Rd, Paramus, New Jersey 07652. The purpose of this contract is to supply the Department of Defense (DoD) with OctaplasLG Powder (blood group types A and AB) for U.S. military forces for the treatment of hemorrhage or coagulopathy during an emergency involving agents of military combat (e.g., firearms, projectiles, and explosive devices) when plasma is not available for use or when the use of plasma is not practical, pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. ? 360bbb-3).
From Special Notice posted on Jul 17, 2025Notice history
1-
Special Notice LATEST Posted Jul 17, 2025
Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
21702